New York, NY – August 10, 2016 – InvestorsHub NewsWire -- Wall Street Corner Report continues to keep an eye on Puration, Inc. (PURA) as a yet undiscovered and we believe, cannabis sector up and comer.
 
PURA Progress Over The Last 30 Days
 
PURA came to life on July 8, 2016 introducing a business plan to bring a US Patent backed cannabis extraction process to market by signing collaboration agreements with food and beverage companies to infuse PURA cannabis extracted concentrates into food and beverage consumer products.  Shortly thereafter, the Company released a $3 million revenue forecast.  Almost one month later, on August 2, 2016, Puration announced its first collaboration agreement.
 
8 M Shares Traded; 50 M I/0; $0.04 Wtd PPS; Expanding Shareholder Base
 
In the 2 years leading up to July 8, 2016, the Company only traded 500,000 shares.  Since July 8th, the Company has traded 8 million shares.  With so little trading volume over the 2 previous years and only 50 million shares issued and out, the recent trading volume has been vital to expanding a shareholder base.  We anticipate further trading under $0.10 as the shareholder base continues to expand.
 
The 52 week PPS range is $0.0071 - $0.10.  With the onset of more meaningful trading since July 8, 2016, the range has been $0.025 - $0.089.  The wtd avg PPS is $0.041.  Daily trading volumes have been sporadic but the daily average has been increasing.  So far, the Company has only had one day where the trading volume exceeded 1 million shares.
 
$0.15 PPS Near Term Potential; $0.45 Mid Term Potential; $0.90 Upside Potential
 
Wall Street Corner Report continues to contend that PURA is an entrepreneurial and earlier stage comparable company to GW Pharmaceuticals (GWPH).  Both are developing commercial applications of patented cannabis extracts.
 
GWPH is currently valued and approximately 33 times revenue based on collaboration agreements that include future payments on currently booked revenue.  PURA has signed its first of three anticipated $1 million collaboration agreements.  At a more than 50% discount of GWPH’s valuation (15 times revenue) and accounting for the possible risk of increase to the current 50 million shares issued and out, the recently announced $1 million collaboration agreement at 15 times revenue and allowing for as many as 100 million shares issued and out would equate to a PPS of $0.15.  If PURA is successful in signing the additional collaboration agreements that make up the Company’s $3 million forecast, the valuation formula above would equate to a $0.54 PPS.  At a 50 million issued and outstanding level, the valuation formula above equates to a $0.90 PPS.
 
Wall Street Corner Report is not the only one paying attention to PURA’s potential.  PURA was last week featured by CFN Media Groups:
Puration (PURA) First of Three Anticipated Collaboration Agreements
 
Financial News Media also featured PURA in an article about leading cannabis companies that included PURA amongst other leading companies to include PharmaCyte Biotech, Inc. (OTC: PMCB),GrowLife, Inc. (OTC: PHOT), Hemp, Inc. (OTC: HEMP) & Medical Marijuana, Inc. (OTC: MJNA)

Extraction Technology Becoming Paramount in Cannabis Industry as Consumers Gravitate Towards Concentrates and Higher Quality of Substance

PURA Summer Rally Candidate
 
August is a slow month for the public markets and not the best time to introduce a new business plan for a public company.  PURA’s potential may not be realized until after Memorial Day when the full market returns to work after the summer holidays.  On the other hand, with many public companies gearing down IR and PR efforts during the summer months, a company that ups its IR/PR game during the otherwise slow summer can become a standout and benefit from a summer rally.
 
To learn more about Puration:        www.purationinc.com
Follow Puration on Twitter:            https://twitter.com/Puration710
Visit Puration on Facebook:           https://www.facebook.com/puration/
 
Wall Street Corner Report is the premier discovery site for promising, yet undiscovered small and micro-cap stocks featuring opportunities in an ethical, professional, and responsible manner. We're not fiendishly 'short' sighted nor are we here to dream the impossibly 'long' dream.  We take a practical view on the big ideas of well-intentioned management and look to profit on each reasonably achievable step the well intentioned mangers take toward their big ideas.
 
http://www.wallstreetcornerreport.com/
 
https://twitter.com/WallStCornerRpt
 
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
 

Jack Taylor
info@wallstreetcornerreport.com
 
 

 
 

Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Medical Marijuana (PK) Charts.
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Medical Marijuana (PK) Charts.